All Wars Require Regime Change
Dems Are Not Pleased These Folks Are Running for Senate
Airport Nightmares Over TSA Lines Have Returned
Pete Hegseth Just Said This About Putting Troops on the Ground In Iran
FBI Just Took Huge Action Against ISIS-Inspired NYC Bombers
James Talarico Claims to Love 'Trans Children.' Here's How You Know He Doesn't.
Trump Gets Surprising Boost As New Poll Flips 2026 Narrative on Its Head
The Press in Its Coverage of the NYC Protest Attack, and Now Who...
Why Are Leftist Women So Full of Rage?
The Majority of Democrats May Just Want to Be 'Normal'
CNN Admits Veterans Overwhelmingly Support Operation Epic Fury
California Is Inching Closer to the Possibility of Electing a Republican Governor
Leftist Protester Says 'We Want Everyone Here to Stay' Moments Before Terrorist Threw...
Rep. Andy Ogles Is Angering All of the Right People
Despite Terror Attacks, Dems Vow to Continue DHS Shut Down to Block ICE...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos